Computational Cytology - Past, Present, and Future

 

Liron Pantanowitz, MD, PhD, MHA
Chair of the Department of Pathology
Maud L. Menten Professor of Pathology
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania

 

An overview of computational cytopathology, as applied to the field in the past, how it is being used today and what we can expect moving into the future. The explosion of artificial intelligence within the domain of both computing and healthcare will likely fundamentally change the practice of cytopathology, particularly when combined with advanced molecular diagnostics. Lastly, we will discuss some other challenges associated with utilizing computational cytopathology for patient care and how those are being addressed.

Target Audience

This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.

Learning Objectives

  • Understand the definition of Computational Cytopathology and how it is used in cytopathology practice
  • Be able to understand the history of applied techniques and devices used in the past that were the foundation for current techniques and advances in image analysis for cytopathology
  • Understand the depth and breadth of techniques offered to cytopathologist and that have been investigated recently for cytopathology
  • Understand the difference between machine learning and deep learning and how these techniques are applied to cytopathology images
  • Have a new perspective on a variety of new techniques and devices being developed for computational pathology and appreciate the future impact to our practice
  • Have a broad understanding to the challenges to both developing and implementing computational techniques for cytopathology
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 1.00 California Credits
  • 2.00 CMLE
  • 2.00 Florida Credits
  • 2.00 Participant
Course opens: 
09/24/2024
Course expires: 
09/23/2027
Cost:
$105.00

Presenter(s):
Liron Pantanowitz, MD, PhD, MHA

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
The faculty, committee members, Executive Board and staff who are in position to control the content of this activity are required to disclose to the ASC and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC has reviewed the disclosures and mitigated all relevant financial relationships.

The following individuals have reported financial relationships:
Christopher J. VandenBussche MD PhD: Ad hoc advisory board panel and Consultant – Roche

The following individuals have reported no relevant financial relationships:
Susan Alperstein, MS, CT(ASCP), Kristen Atkins, MD, Catherine Bammert, PhD, CT, MB(ASCP), Christine Booth, MD, Deborah Chute, MD, Amy Clayton, MD, Jacqueline Cuda, BS, SCT(ASCP), Fang Fan, MD, PhD, Beverly Haigler-Daly, BS, CT(ASCP), Michael Henry, MD, Oscar Lin, MD, PhD, Sean McNair, MPH, CT(ASCP), Michelle Reid, MD, Sinchita Roy-Chowdhuri, MD, PhD, Momin Siddiqui, MD, FIAC, Liron Pantanowitz, MD, PhD, MHA, Michelle Reid, MD, Sinchita Roy-Chowdhuri, MD, PhD, Momin Siddiqui, MD, FIAC, Michael Thrall, MD, Vivian Weiss, MD, PhD, Donna Armylagos, BA CT(ASCP), Cheryl K. Arnott, SCT(ASCP), Bonnie Choy, MD, Saroja Devi Geetha, MBBS, Elizabeth Jacobi, MD, Jennifer B. Kernodle-Zimmer, BS, SCT(ASCP), Zaibo Li, MD, PhD, Steven Long, MD, Judy Pang, MD, Ami Patel, MD, Maria Luisa Policarpio-Nicolas, MD, Jose Victor Scarpa Carniello, MD, Sheila Segura, MD, Paul Staats, MD, Peter Wanes, MD

The ASC staff associated with the development of content for this activity reported no relevant financial relationships.

Presenter:
The presenter has the following conflicts of interest or financial relationships to disclose.
Consaltant - AiXmed, Hamamatsu, NTP
Medical Advisory Board - Ibex
Co-Owner - Placenta AI

ACCREDITATION AND DESIGNATION STATEMENTS

Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

American Board of Pathology Continuing Certification (CC)
This product can help fulfill the CME requirements mandated by the American Board of Pathology Continuing Certification (CC) process.  Earn up to 2.0 Credit Hours.

Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians.  The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 1.00 California Credits
  • 2.00 CMLE
  • 2.00 Florida Credits
  • 2.00 Participant

Price

Cost:
$105.00
Please login or register to take this course.